Arrhythmias-Targeting Compound 1

Names

[ CAS No. ]:
335619-12-0

[ Name ]:
Arrhythmias-Targeting Compound 1

[Synonym ]:
Arrhythmias-Targeting Compound 1

Biological Activity

[Description]:

Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.

[Related Catalog]:

Signaling Pathways >> Others >> Others
Research Areas >> Cardiovascular Disease

[In Vivo]

Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, in particular atrial and ventricular arrhythmias[1].

[References]

[1]. Björe, Annika, et al. NEW OXABISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS. WO 2001028992 A2.


[Related Small Molecules]

Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Crotaline

Chemical & Physical Properties

[ Molecular Formula ]:
C22H32N4O2

[ Molecular Weight ]:
384.51500

[ Exact Mass ]:
384.25300

[ PSA ]:
68.60000

[ LogP ]:
2.30928

Related Compounds